APA (7th ed.) Citation

McKeigue, P., Porter, D., Hollick, R., Ralston, S., McAllister, D., & Colhoun, H. (2023). Risk of severe COVID-19 in patients with inflammatory rheumatic diseases treated with immunosuppressive therapy in Scotland. Scandinavian Journal of Rheumatology, 52(4), 412. https://doi.org/10.1080/03009742.2022.2063376

Chicago Style (17th ed.) Citation

McKeigue, PM, D. Porter, RJ Hollick, SH Ralston, DA McAllister, and HM Colhoun. "Risk of Severe COVID-19 in Patients with Inflammatory Rheumatic Diseases Treated with Immunosuppressive Therapy in Scotland." Scandinavian Journal of Rheumatology 52, no. 4 (2023): 412. https://doi.org/10.1080/03009742.2022.2063376.

MLA (9th ed.) Citation

McKeigue, PM, et al. "Risk of Severe COVID-19 in Patients with Inflammatory Rheumatic Diseases Treated with Immunosuppressive Therapy in Scotland." Scandinavian Journal of Rheumatology, vol. 52, no. 4, 2023, p. 412, https://doi.org/10.1080/03009742.2022.2063376.